Interpreta was named a Top 10 Genomics Solution Provider in 2017 by Pharma Tech Outlook Magazine and is featured in this month’s issue. Pharma Tech Outlook actively tracked 300 nominations, reviewed reports, industry news, social media and surveys with potential buyers, as well as conducted independent research, to arrive at the top 10. Read more about Interpreta being recognized for interpreting genomic, clinical, and FDA guidelines to tailor care for improved clinical outcomes.

Read the full article here